ImpediMed
Australia - PinkenbaBiotechnology
Focus: ImpediMed develops bioimpedance spectroscopy devices for non-invasive clinical assessment and monitoring of tissue composition and fluid status, operating as a specialized medical device company.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
2
Should You Work at ImpediMed?
AI assessmentImpediMed is a highly specialized device company with limited hiring momentum and unclear commercial trajectory—suitable only for candidates seeking niche medical device expertise or willing to join during potential restructuring.
Why Work Here
- Focused technology platform (bioimpedance spectroscopy) with applications across multiple therapeutic areas including heart failure, lymphedema, and cancer
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Growth
Flagship multi-indication device with evidence in heart failure monitoring and cancer-related lymphedema assessment.
Pipeline & Clinical Trials
Help build intelligence for ImpediMed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.